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REVIEW ARTICLE
Making research ethics review work in Zimbabwe —- the case for
investment in local capacity
*J M IELKE **P NDEBELE
Abstract
Objective: To describe the status of ethics review as pertaining to medical research in Zimbabwe, to compare 
this with international guidelines, and thus to identify potential improvements in the process.
Design: The description includes background about the national review body, the Medical Research Council 
of Zimbabwe (MRCZ), and the findings of an analysis of institutional ethics review performed by the MRCZ 
liaison office.
Results: Discrepancies with international guidelines include application of the concepts of independent and 
competent review, monitoring of ongoing studies, and ensuring appropriate membership of institutional 
ethics review committees (IRECs);
Conclusion: A focus on research ethics education for researchers and IREC members, as well as ensuring 
appropriate respect for IREC review, are opportunities for improvement in the process. /
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Introduction
Much has been written in recent years about the need to 
improve research ethics review in developing countries. 
Because of the involvement of researchers and sponsors 
from North America and Europe, including pharmaceutical 
companies, in clinical trials involving human subjects in 
developing countries, concerns about exploitation and 
ethical imperialism (imposing the standards of another 
country on research performed ) have been raised. 
International guidelines have been revised, and new ones 
developed, with greater emphasis on local expertise, 
relevance and policies. In some countries, significant levels 
of sophistication in terms of the protection of research 
participants are demonstrated, for example India has 
published “Ethical guidelines for biomedical research on 
human subjects”.
However, the operational groups (institutional research 
ethics committees [IRECs], also called research ethics 
boards and institutional review boards) which are relied 
upon so heavily everywhere to implement guidelines, 
policies and rules, are critically under-equipped for this 
task in many developing countries, virtually guaranteeing 
failure of human subject protection.
This paper describes and analyses the situation in 
Zimbabwe, a typical sub-Saharan country, in an effort to 
plan effective improvements in research ethics review in a 
developing country.
Background.
In 1974, the then Rhodesian government set up the 
Medical Research Council, now called the Medical 
Research Council of Zimbabwe (MRCZ), by an act of 
parliament.1'2 (This was shortly after the US created its 
national Commission for the Protection of Human Subjects 
of Biomedical and Behavioural Research.) The MRCZ is 
semi-autonomous and has 14 members representing 
different stakeholders such as the Zimbabwe Medical 
A ssociation (ZIM A), L ife Offices A ssociation, 
Universities, and National Association of Medical Aid 
Societies. The chairperson is nominated by the Minister of 
Health. The council has a mandate to regulate research by 
review, approval and monitoring, but has limited legal 
powers. At the present time it reviews about 150 proposals 
a year, of which about 30 are from outside the country. 
(However, many proposals are NOT reviewed by the 
MRCZ, due to inadequate enforcement of regulations). 
Some policy directives and guidelines have been issued 
from time to time, such as the “Guidelines on the collection 
o f blood samples for research purposes. ’’ The emphasis 
has been on building a relationship of trust between all the 
stakeholders involved in research with the MRCZ playing 
a facilitatory role. Some efforts toward revising the 
appropriate piece of legislation have been initiated recently, 
attempting to give the MRCZ authority to deal with non- 
conforming researchers. One major problem in trying to 
drive toWards a regulatory system has been the limited 
capacity of the MRCZ in terms of financial and human 
resources necessary.
Another body charged with reviewing medical research 
is the Medicines Control Authority of Zimbabwe, which 
has regulatory powers over clinical trials involving the 
testing of medical drugs and devices.
After a workshop hosted by the MRCZ itf 1994, 
Institutional Ethical Review Boards (IERBs, here called 
IRECs) were set up in major institutions. The intention'was 
that research proposals would be reviewed at the 
researchers’ home institution first, and passed on to the 
MRCZ with recommendations, for final review and 
approval. Proposals from foreign investigators, including 
pharmaceutical companies, would go from IRECs to the 
Research Council of Zimbabwe before they are submitted 
to the MRCZ or to both the MRCZ and or MCAZ. In the 
subsequent sections some of the problems encountered 
with these IRECs will be discussed.
Formation of IRECs.
These were first formed in 1995 after a workshop on 
Ethical Issues in Reproductive Health Research hosted by 
MRCZ ancl sponsored by WHO-AFRO, in response to the 
increasing number of HIV/AIDS studies and the-ethical 
issues that relate to such studies e.g. confidentiality.3 
Difficulties for the IRECs.
Recent analysis of ethics review by the MRCZ liaison 
office revealed a number of problems for IRECs from the 
perspective of local bodies:
1. Little was done in the way of providing written or 
other guidelines and support on how the IRECs were 
to function.
2. There was little communication or other follow up 
between IRECs and MRCZ.
3. Consequently, the reviewprocedures and their quality . 
have not been standardised
4. Without adequate guidelines and standardisation, 
review procedures have been incomplete and 
inadequate.
5. At the. time of IREC formation, and subsequently, 
there has been no training for IREC members and 
reviewers.
6. Many reviewers have no background to equip them 
specifically for research ethics review, and would be 
more comfortable with purely scientific review.
7. After six years, some IRECs are no longer functioning, 
with some operating nominally only, or as one man 
committees. This is probably a symptom of a number 
of other problems.
8. IREC membership is voluntary, unpaid and not 
recognized as legitimate professional activity by 
management in the tertiary institutions. Thus 
participation in IREC work, despite being arduous 
and time-consuming, is time spent away from “real” 
work, which may place members at academic or 
financial disadvantage. Although these complaints 
are not unique to the developing world, they are more 
pressing, given the large range of responsibilities 
with which health professionals there are routinely 
burdened in their circumstances of staffing shortages.
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With poor motivational factors of this nature, it is 
r;' .'hardly surprising that nonattendance and drop-out 
rates from IREC meetings1 are unworkably high.! ■'
9. ■ Ethics'education and awareness among researchers is 
hot at a high' level; ethics review is regarded as a 
nuisance,-arid many investigators do riot submit their 
' •'' proposals to IRECs for review if possible.' When h‘ 
“sign-off’ from a local ethics research board is
- -:: - required fo r' overseas -funding agencies,1' the single'
surviving member of the IREC (usually the 
" chairpersbrij 'frequeritly also the administrative head
■ of -the'institution) provides a convenient signature.
- Thus much rnore ethics education at the level of
- " training' fo r investigators' (m edical school
undergraduate and post graduate courses) is needed 
if researchers are to be motivated to submit their 
research proposals to research ethics review boards 
willingly; : .-.y
10;; Without effective monitoring of research, the IRECs 
'* • have no “teeth”.'As there are already many constraints
to designing and carrying oiit'research'in'seriously' 
resource-limited environrhehts’, researchers will often' 
cut comers' where they can, realizing' that- this will 
' improve the likelihood of being able to carry-out the 
project. Paradoxically, stringent review requiferrienfs: 
may prevent rriariy worthwhile research efforts. If 
■research was simply not permitted without ethics 
clearance, all studies would be submitted. Moriltoring
■ vis expensive';'however, and dedicated staff would be-
required. : 1 ’ "
l l 1.1 'Limited-support -from government, in the way of 
financial and admiriistrative assistance, has two 
results. Firstly, it suggests to the IRECs that they are' 
of no great importance to the Ministry of Health, so 
that they should not take their task too seriously.
- ■ 'Secondly, the many aspects'involved in the'logistics
■ ofruririing meetings effectively (contacting members 
in time, distributing minutes and proposals, executing
■ decisiorisj-' contacting' investigators,- gathering
■ informatiori, arranging educational activities, etc.)
are perforated much less well without dedicated, 
employed staff. - ’ ■ . ■
12. The quantity of research iri some developing country 
- institutions iria-y not.be as much as in similarly-sized 
facilities in North America or-Europe. Consequently 
a separate IREC, with all the commitment that eritails, - 
’ may be both'unnecessary and difficult to sustain for 
' each institution. On the otherhand, the more removed 
' a comniittee is from'the site of the research, the less 
likely it is to-adequately consider local factors.
How should IRECs function?
In this section, guidelines for the functioning of IRECs 
are' described.-These have been effectively formulated by 
experts', and are here paraphrased from the “Operational \  
guidelines for Ethics Committees that review Btdmedical 
Research” that -were developed by the World Health 
Organization.4 On the. basis of these.guidelines suggestions
forthe resolution of the difficulties described in theprevious, 
section will be atteiripted.
1) Purpose — I RECs exist to protect subjects of medical 
research, in the case of huriiah participants by guardirig
" respect for persons, and by ensuring that the benefits 
and burdens of rriedical research are distributed justly , 
They do'this through -  , - . T . . ...
a) Indep enderiland competent review of the etliics 
of proposed studies. l
b) Ensuring regular monitoring of ongoing studies.
c) Making decisions in the interest of potential 
T  ' research subjects .as well as their communi ties.
2) Membership — IRfiCs require members: .: ,
a) From different disciplines and sectors, thus., 
reflecting balanced age, gender and in 
m ulticultural societies cu ltural/e thnic  
composition; ' . . . .  .1,, -.
i , b) Who arc laypersons, preferably from , the 
, communities which are proposed to be studied;
c) , .With understanding; of the scientific aspects of
. ... . the proposals:
d) Without conflict of interest....
r ; IRECs consist o f some members who fall into
.category (b), otherswho are(c). A ll willbenefit 
.. from ongoing, education in research ethics.: ,
3) Review— this should consist of a critical analysis of:
a) Scientific design and methodology., (validity;-;
, harm-benefit analysis, justificationfor.contro}s, 
stopping rules, m onitoring procedures,
.. publication plans);. - . ■ ;.
b) Research subjects recruitment ( study and.sample 
.-populations and,.demographics, recruitment.
- , procedures;.inclusion and exclusion criteria); ■; 
-c) Research subjects protection . (investigator- 
, competencc,justificationfor any withdrawal o r , 
... withholding of standard therapy, health care for .
. ; . research subjects; .arrangements for ongoing'
access to the study product after the study,
. -. -compensation and-costs to subjects); i- :
d) ; Confidentiality for subjects (-who will have
■access, to personal data, :and how willrthis . 
information be kept private); ■ ' . ; .
e) Informed'consent process (adequacy ■ of-the . 
- ’ informing-process, clear justification fo i -
. : inclusion , of individuals who cannot: give '
• • - consent); ’■ - '
f) -Community .considerations (. local relevance; '
impact, consultations,-influence of'community ' 
on individual consent, local h ea lth 1 care 
development). •■' ’ ''-:
4) Decisions — should only be reached: -
a) ' By a quorum of members who have reviewed -
the application; "
b) After sufficient time for discussion has been '
permitted; -' ■' ■ ' '' :
c) By members without a conflict of interest (if 
such a conflict is present, the. affected member
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shquld be excused from the room for that 
, review); .
. d) ■ Through consensus if,possible (if not,' by a 
, previously defined voting arrangement);
. . .  e ) . With clearly, stated written reasons which will 
be communicated i to investigators, including 
, , suggestions for revision.. ;
Opportunities for improvements.
Comparing the ideals immediately above, and therealities 
of Zimbabwe, what can be done to enhance the process?
a) “Independent and competent review of the ethics of 
proposed studies:”
Independence can only be achieved by ensuring that no 
undue influence on decisions is exerted by other individuals 
and bodies, such as the parent institution, government 
ministries etc, Aformal enshrining.qfthe independence of 
the IREC in a charter or constitution, may help, but only 
partially. The • expectations. ,of influential .investigators 
bringing international drug trials with the.promise.of.great. 
national benefit to the IREC. of a .developing country 
hospital, for example, may be very difficult , to, resist. 
Effective solutions can only be sought in a long-term effort 
to inculcate ethics concerns into the mind-set of all 
researchers. In other words, research ethics needs to be a 
part of the training (and continuing medical education) of 
all medical researchers.
Competence is critical, and entails having adequately 
trained individuals performing the task assiduously and 
scrupulously. There are many stumbling blocks to be 
overcome (see points five and six of difficulties for the 
IRECs above). With a much smaller pool from which to 
draw suitable IREC members, many developing countries ’ 
institutions end up with committees composed of ill-suited 
individuals. Poor recognition of IREC work,- and 
overcommittment of health professionals (including 
personal affairs, e.g. private practice, because of poor 
remuneration), are sure predictors of-irregular and. 
■ unenthusiastic participation. To overcome these, IREC 
membership could be associated with academic prestige 
/(e.g. promotion prospects), financial incentive, and strict 
criteria, so that it becomes a matter of pride to be invited to 
join such a group. Since few eligible candidates may exist 
in a single institution, one IREC could be-formed for" a7 
number of. institutions, for example a single IREC for all 
research in Harare. This would also be commensurate with 
the likelihood of fewer applications in a single institution 
( than in a comparably sized one in the developed world. 
r(See 12. above), but does introduce the difficulty of needing 
to make sure that the IREC reviewers are familiar with 
each institution’s details as they relate to a research 
environment, even if they are no t connected to that institute 
(for example research emanating from a psychiatrichospital 
has ethical problems which may be unfamiliar to reviewers 
not connected with such a hospital).
b) Ensuring regular monitoring of ongoing studies.
Monitoring of studies is difficult, not only in developing
countries. Many large projects have their own data safety
monitoring boards, designed to be independently critical, 
and a regular report from such a board to the IREC on- the 
progresS'Of a study could fulfill this requirement/It mustbe 
remembered that, the data safety monitoringEcjard/is not 
primarily concerned with all ethicabaspects of the study, 
however* and may not be,as-scrupulous, for example; in 
reporting changes in community perceptions ,and desires 
regarding a drug trial, as it-might be about adverse drug 
events. Nevertheless, a truly independent monitoring system 
for . all research- may simply not be feasible . for many 
developing countries, and the co-operation arid compliance 
of investigators will need to,be relied on in any. attempts to 
monitor ongoing work. The establishment of .'independent 
monitoring units risks outrage by public health officials 
perceiving unwarranted expenditure-of; precious public 
funds. Requirements for the annual renewal- of licensing of 
a project, with submission of interim results, would assist 
the process without much financial, burden.
c) Ensuring appropriate membership of the IREC.
In addition-to, the'-points.-in (a) above,:-improving 
lqiowledge- of current IREC - members can significantly 
change the way decisions are reached. .Providing training, 
in the: form of short courses (one to three.days), reading 
material,, and- ,short presentations by visiting experts at 
IREC meetings, may strike the balance between the need 
to impart-information, and the-limited time, available to 
IREC pfembers for educational activities. This- is an 
important area for international agencies to contribute to in., 
terms: of.experience and funding—- for example a two 
week course for 50 IREC members from Africa and Asia 
held by the NIH or the Nuffield Foundation, with the 
contributions of experts from developed and developing 
countries, would begin to address many difficulties 
experienced by those reviewers. Sponsorship for. 
participation in the Global Health Forum for Research 
Ethics could lead to the formation of networks and linkages 
, between reviewers and bioethicists.
One' difficult issue concerns the presence of eminent 
personalities. Respected individuals . can , exert - 
disproportionately effective influence by virtue of their 
V standing in the institutional community, and cause skewed 
decision-making. The solutions are to either re-train such 
an individual to permit other opinions to be included, or to 
persuade him or her to stand down from the IREC. Neither 
option is easy,to carry out. It can be seen that the chairperson . 
of the IREC plays a vital role, and should ideally be a 
respected and capable individual capable of motivating his 
or her committee to enact what may be, quite radical 
changes. There is, therefore, an argumenfto be made in 
favour of efforts to increase capacity especially by 
concentrating on IREC chairpersons.
d) “Reviews should consist of.........”
Since clear guidelines for IREC reviews are now available, 
these should be appropriated (altered where deemed 
necessary), discussed and debated at training sessions, 
made available in a permanent form to each IREC member 
(for example a laminated sheet), and adhered to by the
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chairperson when conducting meetings. As in a number of 
other improvements, the problem of financial and other 
administrative support becomes important and merits being- 
drawn to the attention of relevant policy-makers.
e) “Decisions should only be reached. .  .by members 
without a conflict of interest.”
Once again, the small numbers of eligible reviewers may 
render the suggested process difficult to follow. In addition, 
many reviewers are not aware of more subtle conflicts — 
they could be influenced by the prospect of more 
international recognition of a participating institution, the 
arrival locally of world renowned experts, and other indirect 
benefits. Lastly, the unfortunate possibility of IREC 
members becoming corrupted (bribed) should also be 
guarded against.
Conclusion
Recommendations for action in Zimbabwe.
1. Formally enshrine the independence of all IRECs in 
a charter or constitution.
2. Ensure appropriate IREC membership by associating 
with academic prestige (e.g. promotion prospects), 
financial incentive, and strict criteria,, so that it 
becomes a matter of pride to be invited to join such a 
group.
3. Require a data safety board of larger studies, and at 
minimum annual renewal of licensing of all projects.
/
4. Provide training to improve knowledge of current 
IREC members, in forms appropriate to them, (an 
important area for international agencies to contribute 
in terms of experience and funding), and especially 
for chairpersons of IRECs.
5. Make easily accessible forms of IRECs review 
guidelines available to all members.
6. Form one IREC to function for a number of 
institutions.
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